C
Centrum Medyczne EuroMedis | Szczecin, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
LY3372689
LY3002813
Donanemab
AVP-786
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...
Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo
Locations recently updated
The purpose of this study is to assess the safety, tolerability and effect of study drug LY3372689 in participants with early symptomatic Alzheimer's...
Active, not recruiting
Alzheimer Disease
Drug: LY3372689
Drug: Placebo
This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...
Enrolling
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems